Moreover, cancer patients with significantly altered expression of CISD1 have lower survival rates and worse prognoses, and its expression is significantly correlated with tumor stemness indices in multiple cancers, highlighting its importance prognostic prediction as a crucial prognostic biomarker. This evidence concerns the gene CISD1 and cancer.